[1] Ke L, Li G, Mao W, Doig G, Chen T, Li C, Qu C, Wang L, Gao L, He W, Xia L, Guo F, Lin Y, Feng Q, Liu Z, Li B, Jaber S, Papachristou G, Zhu Y, Liu Y, Windsor J, Tong Z, Li W*, Chinese APCT. Early versus delayed catheter drainage for patients with necrotizing pancreatitis and early persistent organ failure (timing): a multicenter randomized controlled trial. Intensive Care Med, 2025, 51(8), 1431-1441.
[2] Ke L, Ye B, Huang M, Chen T, Doig G, Li C, Chen Y, Zhang H, Zhao L, Chen G, Tu S, Fu L, Xia H, Yang D, Wu B, Ye B, Zhang G, Yang M, Li Q, Chen X, Pan X, Mao W, Buxbaum J, Jaber S, Tong Z, Liu Y, Windsor J, Bellomo R, Li W*, Chinese APCT. Balanced solution versus normal saline in predicted severe acute pancreatitis: a stepped wedge cluster randomized trial. Ann Surg, 2025, 281(1), 86-94.
[3] Yuan C, Xu Y, Lu G, Hu Y, Mao W, Ke L, Tong Z, Xia Y, Ma S, Dong X, Xian X, Wu X, Liu G, Li B, Li W*. Aav-mediated hepatic lpl expression ameliorates severe hypertriglyceridemia and acute pancreatitis in gpihbp1 deficient mice and rats. Molecular therapy : the journal of the American Society of Gene Therapy, 2024, 32(1), 59-73.
[4] Zhou J, Wang Z, Liu Q, Cao L, De-Madaria E, Capurso G, Stoppe C, Wu D, Huang W, Chen Y, Liu S, Hong D, Sun Y, Zeng Z, Qin K, Ni H, Sun Y, Long Y, Guo F, Liu X, Zheng X, Zhang G, Zhang X, Zhou K, Chen Y, Jiao Q, Zou X, Luo X, Li G, Ye B, Li C, Wang L, Li S, Windsor J, Liu Y, Tong Z, Li W, Ke L, Chinese APCT. Triglyceride-lowering therapies in hypertriglyceridemia-associated acute pancreatitis in china: a multicentre prospective cohort study. BMC Med, 2024, 22(1), 535.
[5] Ke L, Mao W, Shao F, Zhou J, Xu M, Chen T, Liu Y, Tong Z, Windsor J, Ma P, Li W, Chinese APCT. Association between pretreatment lymphocyte count and efficacy of immune-enhancing therapy in acute necrotising pancreatitis: a post-hoc analysis of the multicentre, randomised, placebo-controlled trace trial. EClinicalMedicine, 2023, 58, 101915.
[6] Zhu Q, Yuan C, Dong X, Wang Y, Li B, Tu B, Chen W, Xu X, Gong W, Xiao W, Ding Y, Hu L, Li W, Lu G. Bile acid metabolomics identifies chenodeoxycholic acid as a therapeutic agent for pancreatic necrosis. Cell reports. Medicine, 2023, 4(12), 101304.
[7] Cao L, Chen Y, Liu S, Huang W, Wu D, Hong D, Wang Z, Sun Y, Qin K, Guo F, Luo C, Jiao Q, Luo X, Zhou J, Li G, Ye B, Chen T, Liu M, Mao W, Wang L, Li S, Windsor JA, Liu Y, Ke L, Tong Z, Li W, Chinese APCT. Early plasmapheresis among patients with hypertriglyceridemia-associated acute pancreatitis. JAMA Netw Open, 2023, 6(6), e2320802.
[8] Ke L, Lin J, Doig GS, van Zanten ARH, Wang Y, Xing J, Zhang Z, Chen T, Zhou L, Jiang D, Shi Q, Lin J, Liu J, Cheng A, Liang Y, Gao P, Sun J, Liu W, Yang Z, Zhang R, Xing W, Zhang A, Zhou Z, Zhou T, Liu Y, Tong F, Wang Q, Pan A, Huang X, Fan C, Lu W, Shi D, Wang L, Li W, Gu L, Xie Y, Sun R, Guo F, Han L, Zhou L, Zheng X, Shan F, Liu J, Ai Y, Qu Y, Li L, Li H, Pan Z, Xu D, Zou Z, Gao Y, Yang C, Kou Q, Zhang X, Wu J, Qian C, Zhang W, Zhang M, Zong Y, Qin B, Zhang F, Zhai Z, Sun Y, Chang P, Yu B, Yu M, Yuan S, Deng Y, Zhao L, Zang B, Li Y, Zhou F, Chen X, Shao M, Wu W, Wu M, Zhang Z, Li Y, Guo Q, Wang Z, Gong Y, Song Y, Qian K, Feng Y, Fu B, Liu X, Li Z, Gong C, Sun C, Yu J, Tang Z, Huang L, Ma B, He Z, Zhou Q, Yu R, Tong Z, Li W, Chinese CCNT. Actively implementing an evidence-based feeding guideline for critically ill patients (need): a multicenter, cluster-randomized, controlled trial. Critical care (London, England), 2022, 26(1), 46.
[9] Li G, Li S, Cao L, Mao W, Zhou J, Ye B, Zhang J, Ding L, Zhu Y, Ke L, Liu Y, Tong Z, Li W. Nomogram development and validation for predicting minimally invasive step-up approach failure in infected necrotizing pancreatitis patients: a retrospective cohort study. International journal of surgery (London, England), 2023, 109(6), 1677-1687.
[10] Ma N, Yuan C, Shi J, Zhu Q, Liu Y, Ma X, Li B, Gong W, Xue J, Lu G, Li W, Li J. Interleukin-37 protects against acinar cell pyroptosis in acute pancreatitis. JCI insight, 2022, 7(21), e161244.
